Titre : Bas de contention

Bas de contention : Questions médicales fréquentes

Termes MeSH sélectionnés :

Programmed Cell Death 1 Receptor
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Bas de contention : Questions médicales les plus fréquentes", "headline": "Bas de contention : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Bas de contention : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-12", "dateModified": "2025-05-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Bas de contention" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Bandages de compression", "url": "https://questionsmedicales.fr/mesh/D058128", "about": { "@type": "MedicalCondition", "name": "Bandages de compression", "code": { "@type": "MedicalCode", "code": "D058128", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E07.101.400" } } }, "about": { "@type": "MedicalCondition", "name": "Bas de contention", "alternateName": "Stockings, Compression", "code": { "@type": "MedicalCode", "code": "D053828", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Moacir Marocolo", "url": "https://questionsmedicales.fr/author/Moacir%20Marocolo", "affiliation": { "@type": "Organization", "name": "e Physiology and Human Performance Research Group, Department of Physiology , Federal University of Juiz de Fora , Juiz de For a , Brazil." } }, { "@type": "Person", "name": "Jichun Zhao", "url": "https://questionsmedicales.fr/author/Jichun%20Zhao", "affiliation": { "@type": "Organization", "name": "Department of Vascular Surgery, West China Hospital, Sichuan University, Chengdu, China." } }, { "@type": "Person", "name": "Wen-Tao Yang", "url": "https://questionsmedicales.fr/author/Wen-Tao%20Yang", "affiliation": { "@type": "Organization", "name": "Department of Vascular Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China." } }, { "@type": "Person", "name": "Hua-Liang Ren", "url": "https://questionsmedicales.fr/author/Hua-Liang%20Ren", "affiliation": { "@type": "Organization", "name": "Department of Vascular Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Response to programmed cell death protein 1 antibody in patients with Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.", "datePublished": "2023-09-09", "url": "https://questionsmedicales.fr/article/37862797", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejca.2023.113337" } }, { "@type": "ScholarlyArticle", "name": "Lichen Planopilaris Pemphigoides: A Novel Bullous Dermatosis Due to Programmed Cell Death Protein-1 Inhibitor Therapy.", "datePublished": "2023-02-20", "url": "https://questionsmedicales.fr/article/36825932", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/DAD.0000000000002392" } }, { "@type": "ScholarlyArticle", "name": "Programmed Death 1 (PD-1) Expression in Relapsing and Remitting Hodgkin Lymphoma as Prognostic Factor.", "datePublished": "2023-08-01", "url": "https://questionsmedicales.fr/article/37642071", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.31557/APJCP.2023.24.8.2829" } }, { "@type": "ScholarlyArticle", "name": "Analysis of Programmed Cell Death-1 (PD-1) Gene Variations (re11568821 and rs41386349) in HTLV-1 Infection Using One Primer Pair and Proviral Load.", "datePublished": "2023-04-05", "url": "https://questionsmedicales.fr/article/37020064", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00239-023-10104-5" } }, { "@type": "ScholarlyArticle", "name": "Programmed cell death protein 1 axis blockade in locally advanced squamous cell carcinoma of the head and neck: Neoadjuvant and adjuvant approaches.", "datePublished": "2022-07-16", "url": "https://questionsmedicales.fr/article/35868194", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ctrv.2022.102437" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Équipement et fournitures", "item": "https://questionsmedicales.fr/mesh/D004864" }, { "@type": "ListItem", "position": 3, "name": "Bandages", "item": "https://questionsmedicales.fr/mesh/D001458" }, { "@type": "ListItem", "position": 4, "name": "Bandages de compression", "item": "https://questionsmedicales.fr/mesh/D058128" }, { "@type": "ListItem", "position": 5, "name": "Bas de contention", "item": "https://questionsmedicales.fr/mesh/D053828" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Bas de contention - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Bas de contention", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Bas de contention", "description": "Comment diagnostiquer une insuffisance veineuse ?\nQuels signes indiquent le besoin de bas de contention ?\nQuels tests sont nécessaires avant de prescrire des bas de contention ?\nLes bas de contention sont-ils adaptés à tous les patients ?\nComment évaluer l'efficacité des bas de contention ?", "url": "https://questionsmedicales.fr/mesh/D053828?mesh_terms=Programmed+Cell+Death+1+Receptor&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Bas de contention", "description": "Quels symptômes nécessitent des bas de contention ?\nLes bas de contention soulagent-ils les crampes ?\nComment les bas de contention affectent-ils l'enflure ?\nLes bas de contention soulagent-ils les démangeaisons ?\nLes bas de contention améliorent-ils la fatigue des jambes ?", "url": "https://questionsmedicales.fr/mesh/D053828?mesh_terms=Programmed+Cell+Death+1+Receptor&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Bas de contention", "description": "Comment prévenir les problèmes veineux ?\nLes bas de contention sont-ils efficaces pour prévenir les varices ?\nQuelles habitudes de vie favorisent la santé veineuse ?\nLes bas de contention sont-ils recommandés pour les voyages longs ?\nComment l'alimentation influence-t-elle la santé veineuse ?", "url": "https://questionsmedicales.fr/mesh/D053828?mesh_terms=Programmed+Cell+Death+1+Receptor&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Bas de contention", "description": "Comment choisir la taille des bas de contention ?\nQuelle est la durée de port recommandée pour les bas de contention ?\nLes bas de contention sont-ils remboursés par la sécurité sociale ?\nPeut-on porter des bas de contention pendant la grossesse ?\nLes bas de contention sont-ils disponibles en différentes classes ?", "url": "https://questionsmedicales.fr/mesh/D053828?mesh_terms=Programmed+Cell+Death+1+Receptor&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Bas de contention", "description": "Quelles complications peuvent survenir avec des bas de contention ?\nLes bas de contention peuvent-ils aggraver certaines conditions ?\nComment reconnaître une mauvaise utilisation des bas de contention ?\nLes bas de contention peuvent-ils causer des thromboses ?\nQue faire en cas de réaction allergique aux bas de contention ?", "url": "https://questionsmedicales.fr/mesh/D053828?mesh_terms=Programmed+Cell+Death+1+Receptor&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Bas de contention", "description": "Quels sont les facteurs de risque pour les problèmes veineux ?\nLe tabagisme influence-t-il la santé veineuse ?\nLes femmes sont-elles plus à risque de problèmes veineux ?\nL'hérédité joue-t-elle un rôle dans les problèmes veineux ?\nLes professions sédentaires augmentent-elles le risque veineux ?", "url": "https://questionsmedicales.fr/mesh/D053828?mesh_terms=Programmed+Cell+Death+1+Receptor&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une insuffisance veineuse ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un examen clinique et des tests comme l'échographie Doppler sont utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent le besoin de bas de contention ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des douleurs, des œdèmes et des varices visibles." } }, { "@type": "Question", "name": "Quels tests sont nécessaires avant de prescrire des bas de contention ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation de la circulation sanguine et un historique médical sont essentiels." } }, { "@type": "Question", "name": "Les bas de contention sont-ils adaptés à tous les patients ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, certaines conditions comme l'artérite peuvent contre-indiquer leur usage." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité des bas de contention ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'amélioration des symptômes et des examens de suivi permettent d'évaluer leur efficacité." } }, { "@type": "Question", "name": "Quels symptômes nécessitent des bas de contention ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs, lourdeur des jambes, œdèmes et varices sont des symptômes fréquents." } }, { "@type": "Question", "name": "Les bas de contention soulagent-ils les crampes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent réduire les crampes nocturnes en améliorant la circulation." } }, { "@type": "Question", "name": "Comment les bas de contention affectent-ils l'enflure ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils exercent une pression qui aide à réduire l'enflure en favorisant le retour veineux." } }, { "@type": "Question", "name": "Les bas de contention soulagent-ils les démangeaisons ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent aider à réduire les démangeaisons causées par une mauvaise circulation." } }, { "@type": "Question", "name": "Les bas de contention améliorent-ils la fatigue des jambes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent réduire la fatigue en soutenant les veines et en améliorant la circulation." } }, { "@type": "Question", "name": "Comment prévenir les problèmes veineux ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier, l'hydratation et le port de bas de contention aident à prévenir." } }, { "@type": "Question", "name": "Les bas de contention sont-ils efficaces pour prévenir les varices ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent aider à prévenir l'apparition des varices en soutenant les veines." } }, { "@type": "Question", "name": "Quelles habitudes de vie favorisent la santé veineuse ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter la sédentarité, maintenir un poids santé et éviter le tabac sont bénéfiques." } }, { "@type": "Question", "name": "Les bas de contention sont-ils recommandés pour les voyages longs ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont conseillés pour réduire le risque de thrombose lors de longs voyages." } }, { "@type": "Question", "name": "Comment l'alimentation influence-t-elle la santé veineuse ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en fibres et en antioxydants favorise la santé veineuse." } }, { "@type": "Question", "name": "Comment choisir la taille des bas de contention ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "La taille se détermine par des mesures des jambes, comme le tour de cheville et de mollet." } }, { "@type": "Question", "name": "Quelle est la durée de port recommandée pour les bas de contention ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils doivent être portés toute la journée, retirés la nuit, sauf avis contraire du médecin." } }, { "@type": "Question", "name": "Les bas de contention sont-ils remboursés par la sécurité sociale ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sous certaines conditions, notamment sur prescription médicale." } }, { "@type": "Question", "name": "Peut-on porter des bas de contention pendant la grossesse ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont souvent recommandés pour soulager les jambes pendant la grossesse." } }, { "@type": "Question", "name": "Les bas de contention sont-ils disponibles en différentes classes ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils existent en plusieurs classes de compression selon les besoins médicaux." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des bas de contention ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des irritations cutanées, des douleurs ou des problèmes circulatoires peuvent survenir." } }, { "@type": "Question", "name": "Les bas de contention peuvent-ils aggraver certaines conditions ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent aggraver des problèmes comme l'artérite ou des infections cutanées." } }, { "@type": "Question", "name": "Comment reconnaître une mauvaise utilisation des bas de contention ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs accrues, des engourdissements ou des rougeurs peuvent indiquer une mauvaise utilisation." } }, { "@type": "Question", "name": "Les bas de contention peuvent-ils causer des thromboses ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Rarement, mais une mauvaise utilisation peut augmenter le risque de thrombose veineuse." } }, { "@type": "Question", "name": "Que faire en cas de réaction allergique aux bas de contention ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Retirer les bas et consulter un médecin pour évaluer la réaction et les alternatives." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les problèmes veineux ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, la sédentarité, l'âge avancé et les antécédents familiaux sont des facteurs de risque." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la santé veineuse ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut aggraver les problèmes veineux en altérant la circulation sanguine." } }, { "@type": "Question", "name": "Les femmes sont-elles plus à risque de problèmes veineux ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en raison des changements hormonaux, les femmes sont souvent plus à risque." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans les problèmes veineux ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de varices ou d'insuffisance veineuse augmentent le risque." } }, { "@type": "Question", "name": "Les professions sédentaires augmentent-elles le risque veineux ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, rester assis longtemps peut favoriser l'apparition de problèmes veineux." } } ] } ] }

Sources (10000 au total)

Response to programmed cell death protein 1 antibody in patients with Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.

Epstein-Barr virus-associated intrahepatic cholangiocarcinoma (EBVaICC) has a distinct genomic profile and increased CD3... Patients with metastatic biliary tract cancer (BTC) diagnosed at Sun Yat-sen University Cancer Center from January 2016 to December 2021 were identified. In situ hybridisation was performed to detect ... A total of 698 patients with metastatic BTC were identified, of whom 39 (5.6%) had EBVaICC. Among the 136 patients who were not administered PD-1 antibody, the OS was similar between patients with EBV... This study identified a clinically actionable subset of patients with EBVaICC with a promising response to the PD-1 antibody....

Lichen Planopilaris Pemphigoides: A Novel Bullous Dermatosis Due to Programmed Cell Death Protein-1 Inhibitor Therapy.

Lichen planus pemphigoides (LPPemph), apart from bullous pemphigoid, is a rare bullous dermatosis that can be induced by programmed cell death protein-1 (PD-1)/PD ligand 1 (PD-L1) inhibitors. The prim...

Programmed Death 1 (PD-1) Expression in Relapsing and Remitting Hodgkin Lymphoma as Prognostic Factor.

Programmed death ligand 1 (PD-L1) plays critical role in PD-1-dependent immunity suppress. Abnormal PD-L1 expression has shown to be directly related to poor prognosis and drug resistance in cancer pa... In this cross-sectional study, 100 patients with HL between 2007 and 2015, were included. A thin section of tumor tissue fixed and processed on slides, stained by immunohistochemistry (IHC) PD-L1 spec... of 100 HL cases, the mean age of 33 relapsed group cases was significantly higher than remission group (p-value = 0.006), and gender was not significant however majority of cases in both groups were m... PD-L1 expression assessment in HL patients is a valuable tool for prediction of the disease subtype, progression, stage, and treatment outcome. IHC method as an available, simple, rather cheap, and ef...

Analysis of Programmed Cell Death-1 (PD-1) Gene Variations (re11568821 and rs41386349) in HTLV-1 Infection Using One Primer Pair and Proviral Load.

About 90% of people infected with Human T lymphotropic virus type-1 (HTLV-1) virus are asymptomatic, so it can be said that the prevalence of this virus is not completely clear. During chronic infecti...

Programmed cell death protein 1 axis blockade in locally advanced squamous cell carcinoma of the head and neck: Neoadjuvant and adjuvant approaches.

Immunotherapy and in particular programmed cell death protein 1 (PD-1) inhibitors have been applied not only in the management of recurrent or metastatic disease but also as component of potentially c...

Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.

Programmed cell death-1 (PD-1) inhibitor was proven to be useful for the recurrent/metastatic head and neck squamous carcinoma (R/M HNSCC) patients. Though both PD-1 inhibitor alone and combination wi... We consecutively enrolled the R/M HNSCC patients treated with concurrent PD-1 inhibitor and chemoradiotherapy from August 2018 to April 2022 in Sichuan Cancer hospital. All the patients received the c... 40 R/M HNSCC patients were enrolled in our stuty. The median follow up time was 14 months. 22 patients had recurrent disease only, 16 patients had metastatic disease only, and 2 patients had both recu... The synergy of concurrent PD-1 inhibitor treatment with chemoradiotherapy shows promise as a treatment strategy and an acceptable toxicity for the R/M HNSCC patients....

Association between Loss of Immune Checkpoint Programmed Cell Death Protein 1 and Active ANCA-Associated Renal Vasculitis.

Immune checkpoint inhibitors (ICIs) have made an important contribution to the survival of patients with certain cancers. ICIs interrupt co-inhibitory signaling pathways mediated by programmed cell de...

Association of programmed cell death 1 (PD-1) gene polymorphism (rs10204525) with COVID-19 severity and mortality: A case-control study in the Iranian population.

Programmed cell death 1 (PD-1), as a negative immune regulator, regulates the activation of T cells and maintains the immune system's homeostasis. Previous studies suggest that the effective immune re... The PD-1 rs10204525 was genotyped in 810 COVID-19 patients and 164 healthy individuals as a control group using Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Moreover,... Regarding disease severity and mortality, no significant differences were detected between study groups in alleles and genotypes frequency distribution under different inheritance models. We found tha... Considering the lack of significant differences in PDCD-1 expression in different genotypes in the control group, lower expression of PDCD-1 in COVID-19 patients carrying the G allele suggests the imp...